Stay updated on Effectiveness and Duration of Vyvanse in ADHD Clinical Trial
Sign up to get notified when there's something new on the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page.

Latest updates to the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for NCT01070394 is displayed with details about the ADHD study, its treatment, eligibility, outcomes, and record history, replacing a 403 error screen.SummaryDifference48%

- Check14 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study record page now returns a 403 Forbidden error, preventing access to the study details; this indicates an access restriction or outage affecting the page's ability to display its main content.SummaryDifference18%

Stay in the know with updates to Effectiveness and Duration of Vyvanse in ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page.